CRISPR-Cas Gene Editing Technology to Combat Antibiotic Resistance and Sepsis

The objective of my project was to evaluate the potential of CRISPR-based gene editing as a therapeutic strategy for combating antibiotic resistance and sepsis. To achieve this, I conducted a comprehensive literature review of both primary research articles and secondary sources. This enabled me to synthesize current evidence on the underlying mechanisms of CRISPR-based gene editing, its applications in targeting antibiotic-resistant bacteria, its potential role in improving sepsis treatment, and the key challenges and future directions associated with translating this technology into clinical practice.